%Responders to INFLIXIMAB in the cohort (WORLD):
by Thymidine Incorporation (95% CI): %4.6948 (2.8169,6.8075)
by IL-2 ELISpot (95% CI): %0 (0,0.46948)
by Combined Thymidine Incorporation & IL-2 ELISpot (95% CI): %0 (0,0.46948)
--
%Similarity between Thymidine Incorporation & IL-2 ELISpot predictions (95% CI): %95.3967 (93.5163,97.2771)
